ArticleFrontiers in surgery2022

Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection.

Baiyu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.